For instance, in the case of leukemia, exosomes derived from tumor cells with silenced TGF-β1 can effectively promote DC maturation by reducing TGF-β1 expression, resulting in a more effective induction of tumor-specific CTL responses (167). This evidence concerns the gene TGFB1 and neoplasm.